US FDA explains drug label comprehension studies
This article was originally published in Scrip
Executive Summary
The US FDA has issued guidance explaining how sponsors of non-prescription medicines should design label comprehension studies for assessing the extent to which consumers understand the information on a drug label. The guidance deals with the general concepts that should be considered in the design and conduct of such studies.